Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials-Reference-Cited by-同舟云学术

Comparison of Docetaxel- and Vinca Alkaloid–Based Chemotherapy in the First-line Treatment of Advanced Non-small Cell Lung Cancer: A Meta-analysis of Seven Randomized Clinical Trials

Published:2007-10 Issue:10 Volume:2 Page:939-946
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Douillard Jean-Yves,Laporte Silvy,Fossella Frank,Georgoulias Vassilis,Pujol Jean-Louis,Kubota Kaoru,Monnier Alain,Kudoh Shinzoh,Rubio Jaime Ernesto,Cucherat Michel

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference46 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Chemotherapy for non-small-cell lung cancer. Part 1: Early-stage disease;Novello;Oncology (Williston Park),2003

3. 10-year update on chemotherapy for non-small cell lung cancer;Abratt;Ann Oncol,2006

4. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

5. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52. randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group;Non-small Cell Lung Cancer Collaborative Group;BMJ,1995

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traitements systémiques de première ligne dans les CBNPC avancés en l’absence d’addiction oncogénique;Revue des Maladies Respiratoires Actualités;2020-10

2. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503;Lung Cancer;2020-03

3. Traitements de première ligne dans les CBNPC avancés, en l’absence d’addiction oncogénique (incluant le traitement de maintenance et les anti-angiogéniques);Revue des Maladies Respiratoires Actualités;2019-10

4. Microtubule-targeting agents in the treatment of non-small cell lung cancer: insights on new combination strategies and investigational compounds;Expert Opinion on Investigational Drugs;2019-06-03

5. Chimiothérapie de première ligne incluant le traitement de maintenance et les anti-angiogéniques dans les CBNPC avancés en l’absence d’addiction oncogénique;Revue des Maladies Respiratoires Actualités;2018-10